Yahoo
NasdaqCM - BOATS Real Time Price USD

QTREX Quantum Ltd. (QTEX)

2.0100 0.0000 (0.00%)
At close: June 22 at 4:00:00 PM EDT
2.0700 +0.0600 (+2.99%)
Overnight: 1:49:45 AM EDT
Chart Range Bar
Loading chart for QTEX
Chart does not reflect overnight price.
  • Previous Close 2.0100
  • Open 2.2450
  • Bid 1.9900 x 100
  • Ask 2.1300 x 100
  • Day's Range 1.9600 - 2.2800
  • 52 Week Range 0.2830 - 3.8500
  • Volume 12,573,956
  • Avg. Volume 28,421,024
  • Market Cap (intraday) 105.728M
  • Beta (5Y Monthly) 4.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.00

QTREX Quantum Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026. QTREX Quantum Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

q-trex.com

34

Full Time Employees

December 31

Fiscal Year Ends

Technology

Sector

Performance Overview

Trailing total returns as of 6/22/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

QTEX
123.33%
S&P 500 (^GSPC)
9.16%

1-Year Return

QTEX
174.22%
S&P 500 (^GSPC)
25.22%

3-Year Return

QTEX
35.54%
S&P 500 (^GSPC)
70.54%

5-Year Return

QTEX
59.80%
S&P 500 (^GSPC)
75.98%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY23
Revenue --
Earnings --

Q1

FY23

Q2

FY23

Q3

FY23

Q4

FY23

0

Analyst Insights

View More

Analyst Price Targets

5.00
5.00 Average
2.0100 Current
5.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 6/22/2026
  • Market Cap

    105.73M

  • Enterprise Value

    103.05M

  • Trailing P/E

    --

  • Forward P/E

    20.08

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    206.03

  • Price/Book (mrq)

    45.51

  • Enterprise Value/Revenue

    356.57

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -126.98%

  • Return on Equity (ttm)

    -397.89%

  • Revenue (ttm)

    289k

  • Net Income Avi to Common (ttm)

    -13.22M

  • Diluted EPS (ttm)

    -0.4500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.16M

  • Total Debt/Equity (mrq)

    20.66%

  • Levered Free Cash Flow (ttm)

    -5.67M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

2.0100 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: